Palliative electrochemotherapy in primary or recurrent vulvar cancer.

Giacomo CorradoGiuseppe CutilloSimona Maria FragomeniValentina BrunoLuca TagliaferriEmanuela ManciniCamilla CertelliIda ParisEnrico VizzaGiovanni ScambiaGiorgia Garganese

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)

Electrochemotherapy is a feasible, easy to perform, and reproducible procedure in patients with primary or recurrent vulvar cancer who are unable to undergo surgery. Survival after 1 year in this population was 50%. Electrochemotherapy may have a role in the management of vulvar cancer, especially as palliative treatment when other therapies are no longer applicable.

Keyphrases

papillary thyroid
squamous cell
minimally invasive
palliative care
sentinel lymph node
lymph node metastasis
childhood cancer
radiation therapy
coronary artery bypass
young adults
atrial fibrillation
percutaneous coronary intervention
smoking cessation
surgical site infection